AbCellera Biologics Inc (STU:8QQ)
€ 2.727 -0.015 (-0.55%) Market Cap: 793.79 Mil Enterprise Value: 210.54 Mil PE Ratio: 0 PB Ratio: 0.76 GF Score: 59/100

Abcellera Biologics Inc at JPMorgan Healthcare Conference Transcript

Jan 10, 2024 / 10:15PM GMT
Release Date Price: €5.1 (-4.24%)
Cindy Xu JPMorgan Chase;Co.;Analyst

&-

All right. Hello, everyone. Welcome to another year of JPMorgan Healthcare Conference. My name is Cindy Xu. I'm an associate at the JPMorgan Healthcare Investment Banking team. Without further ado, it's my great pleasure to introduce you, Carl Hansen, the CEO of AbCellera. Thank you.

Carl Hansen
AbCellera Biologics Inc - Chairman of the Board, President, Chief Executive Officer, Co-Founder

Thank so much, Cindy, and thanks, everyone, for coming today. It's a pleasure to be here and to reconnect with colleagues at JPMorgan. I was giving a lot of thought as to how I might start this today and I came up with a metaphor, and I'm going to give it a try. We'll see if it lands.

So the metaphor is that building a company is a lot like raising a child. So you found a company, it's small. It's helpless. It needs a lot of support. It takes about 20 years to raise that child to maturity. And if you do it right, if you lay the foundation, you have high hopes that child can go off into the world and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot